Nanobiotix S.A. ADR (NBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -57,025 | N/A | N/A |
| Depreciation Amortization | 1,979 | N/A | N/A |
| Accounts receivable | -95 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,304 | N/A | N/A |
| Other Working Capital | -1,705 | N/A | N/A |
| Other Operating Activity | 8,433 | 0 | 0 |
| Operating Cash Flow | $-46,109 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -18 | N/A | N/A |
| PPE Investments | -1,222 | N/A | N/A |
| Purchase Sale Intangibles | -395 | N/A | N/A |
| Other Investing Activity | -394 | 0 | 0 |
| Investing Cash Flow | $-1,634 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 15,680 | N/A | N/A |
| Common Stock Issued | 34,545 | N/A | N/A |
| Other Financing Activity | -3,758 | 0 | 0 |
| Financing Cash Flow | $46,468 | $N/A | $N/A |
| Exchange Rate Effect | 33 | N/A | N/A |
| Beginning Cash Position | 40,547 | N/A | N/A |
| End Cash Position | 39,305 | N/A | N/A |
| Net Cash Flow | $-1,242 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -46,109 | N/A | N/A |
| Capital Expenditure | -1,222 | N/A | N/A |
| Free Cash Flow | -47,331 | 0 | 0 |